SCRIBE THERAPEUTICS INC
SCTXNASDAQ🏆 #3403 by market capUS Equity
——
Quote unavailableTrack SCTX
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$256M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
No chart data available for SCTX.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $13.50 – $39.60
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 16.2M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
SCRIBE THERAPEUTICS INC
SCTXFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout SCRIBE THERAPEUTICS INC
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.